Depsipeptide, a histone deacetylase inhibitor for treatment of cutaneous T-cell lymphoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL LYMPHOMA & MYELOMA | 2006年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 364
页数：7
相关论文
共 50 条
  • [1] Potential value of the histone deacetylase inhibitor depsipeptide (FR901228) in the treatment of peripheral and cutaneous T-cell lymphoma.
    Piekarz, R
    Robey, R
    Sandor, V
    Fojo, AT
    Bakke, S
    Wilson, W
    Kingma, D
    Turner, M
    Tucker, E
    Bates, SE
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3726S - 3726S
  • [2] Romidepsin: A Histone Deacetylase Inhibitor for Refractory Cutaneous T-Cell Lymphoma
    Kim, Miryoung
    Thompson, Lisa A.
    Wenger, Sarah D.
    O'Bryant, Cindy L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (10) : 1340 - 1348
  • [3] Experience in the treatment of advanced cutaneous T-cell lymphoma with Vorinostat, Histone deacetylase inhibitor (Zolinza®)
    Stadler, R.
    ONKOLOGIE, 2010, 33 : 138 - 138
  • [4] A soft-drug histone deacetylase inhibitor for cutaneous T-cell lymphoma
    Bradner, James
    Greenberg, Edward
    Ponduru, Sridevi
    Patel, Vishal
    Schreiber, Stuart
    Rich, Benjamin
    Mazitschek, Ralph
    BLOOD, 2007, 110 (11) : 246A - 246A
  • [5] Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma
    Duvic, Madeleine
    DERMATOLOGIC CLINICS, 2015, 33 (04) : 757 - +
  • [6] Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
    Duvic, Madeleine
    Vu, Jenny
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) : 1111 - 1120
  • [7] The Role of Histone Deacetylase Inhibitors in the Treatment of Patients With Cutaneous T-Cell Lymphoma
    Hymes, Kenneth B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 98 - 109
  • [8] Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report
    Piekarz, RL
    Robey, R
    Sandor, V
    Bakke, S
    Wilson, WH
    Dahmoush, L
    Kingma, DM
    Turner, ML
    Altemus, R
    Bates, SE
    BLOOD, 2001, 98 (09) : 2865 - 2868
  • [9] Activity of CKD-581, Histone Deacetylase Inhibitor, in Cutaneous T-cell Lymphoma Models
    Kim, M. J.
    Lee, C. S.
    Lee, D. H.
    Yang, H. M.
    Lim, I. T.
    Bae, D. I.
    Choe, Y. J.
    Kim, D. H.
    Kim, S. K.
    Lee, S. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S642 - S642
  • [10] Depsipeptide, a histone deacetylase inhibitor, shows promising clinical activity in T-cell lymphomas
    Reddy, GK
    CLINICAL LYMPHOMA, 2004, 5 (01): : 15 - 16
12345